AAAAAA

   
Results: 1-11 |
Results: 11
Genomics and proteomics converge on Helicobacter pylori
Authors: Bjorkholm, BM Oh, JD Falk, PG Engstrand, LG Gordon, JI
Citation: Bm. Bjorkholm et al., Genomics and proteomics converge on Helicobacter pylori, CURR OPIN M, 4(3), 2001, pp. 237-245
Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models
Authors: Bibbiani, F Oh, JD Chase, TN
Citation: F. Bibbiani et al., Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models, NEUROLOGY, 57(10), 2001, pp. 1829-1834
A monoclonal antibody that induces neuronal apoptosis binds a metastasis marker
Authors: Zhong, LT Manzi, A Skowronski, E Notterpek, L Fluharty, AL Faull, KF Masada, I Rabizadeh, S Varsanyi-Nagy, M Ruan, YL Oh, JD Butcher, LL Bredesen, DE
Citation: Lt. Zhong et al., A monoclonal antibody that induces neuronal apoptosis binds a metastasis marker, CANCER RES, 61(15), 2001, pp. 5741-5748
Regulation of striatal N-methyl-D-aspartate receptor (NMDAR) function by phosphorylation of its subunits in Parkinsonian rats
Authors: Oh, JD
Citation: Jd. Oh, Regulation of striatal N-methyl-D-aspartate receptor (NMDAR) function by phosphorylation of its subunits in Parkinsonian rats, METH MOL M, 62, 2001, pp. 247-253
Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications
Authors: Chase, TN Oh, JD
Citation: Tn. Chase et Jd. Oh, Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications, ANN NEUROL, 47(4), 2000, pp. S122-S130
Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms
Authors: Chase, TN Oh, JD Konitsiotis, S
Citation: Tn. Chase et al., Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms, J NEUROL, 247, 2000, pp. 36-42
Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism
Authors: Chase, TN Oh, JD
Citation: Tn. Chase et Jd. Oh, Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism, TRENDS NEUR, 23(10), 2000, pp. S86-S91
Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain
Authors: Oh, JD Chartisathian, K Chase, TN Butcher, LL
Citation: Jd. Oh et al., Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain, BRAIN RES, 853(2), 2000, pp. 174-185
Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits
Authors: Oh, JD Vaughan, CL Chase, TN
Citation: Jd. Oh et al., Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits, BRAIN RES, 821(2), 1999, pp. 433-442
Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration (vol 813, pg 150, 1998)
Authors: Oh, JD Russell, DS Vaughan, CL Chase, TN
Citation: Jd. Oh et al., Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration (vol 813, pg 150, 1998), BRAIN RES, 820(1-2), 1999, pp. 117-117
Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration
Authors: Oh, JD Russell, D Vaughan, CL Chase, TN
Citation: Jd. Oh et al., Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration, BRAIN RES, 813(1), 1998, pp. 150-159
Risultati: 1-11 |